Cite
HARVARD Citation
Feagan, B. et al. (n.d.). A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY. Journal of the Canadian Association of Gastroenterology. pp. 18-20. [Online].